Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol

As of September 30, 2015, a total of 1589 laboratory-confirmed cases of infection with the Middle East respiratory syndrome coronavirus (MERS-CoV) have been reported to the World Health Organization (WHO). At present there is no effective specific therapy against MERS-CoV. The use of convalescent pl...

Full description

Bibliographic Details
Main Authors:	Arabi, Y, Balkhy, H, Hajeer, A, Bouchama, A, Hayden, F, Al-Omari, A, Al-Hameed, F, Taha, Y, Shindo, N, Whitehead, J, Merson, L, AlJohani, S, Al-Khairy, K, Carson, G, Luke, T, Hensley, L, Al-Dawood, A, Al-Qahtani, S, Modjarrad, K, Sadat, M, Rohde, G, Leport, C, Fowler, R
Format:	Journal article
Language:	English
Published:	SpringerPlus 2015

Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol

Similar Items